Zhangzhou Pientzehuang Pharmaceutical | 600436 - Gewinn Vor Steuern

Aktienkurs
152.69
Täglich Wechseln
0.63 0.41%
Monatlich
-7.95%
Jährlich
-25.94%
Q1 Prognose
152.81




Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Cspc Pharmaceutical CNY 1.21B 110.04M 2025-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
IQVIA Holdings USD 6.16B 5.84B 2025-09
Jiangsu Hengrui CNY 1.36B 1.61B 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Moderna USD -187M 631M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Sh Fosun Pharma CNY 1.12B 252.08M 2025-09
Tectonic Therapeutic USD -18.97M 63K 2025-12
Viatris USD -7.9M 209.2M 2025-09
Wuxi Apptec CNY 5.03B 595.17M 2025-09
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06